Drug recall · June 22, 2016
Pramipexole Dihydrochloride Extended Release Tablets recall
Why: Failed Impurities/Degradation Specifications: Par Pharmaceutical is recalling Pramipexole Dihydrochloride Extended Release tablets because it contains a known product impurity above currently approved specification levels.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Pramipexole Dihydrochloride Extended Release Tablets, 0.375 mg, Rx Only, 30 count bottles, Manufactured By: Par Pharmaceutical Companies, Inc., Chestnut Ridge, NY 10977, NDC 10370-251-11
- Lots / codes
Lot #s: 27409201, 27409301, 27409401, Exp. 02/2017; 27662101, Exp. 07/2017
- Quantity
- 12,535 bottles
- Company
- Par Pharmaceutical, Chestnut Ridge, NY
- Distribution
- Nationwide and Puerto Rico.
- Initiated
- May 28, 2016 · Voluntary: Firm initiated
- Classified
- June 16, 2016
- Reported
- June 22, 2016
- Ended
- March 3, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Pramipexole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.